- $973.59m
- $935.15m
- $305.63m
- 71
- 46
- 84
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 366 | 335 | 304 | 303 | 306 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 255 | 233 | 236 | 227 | 229 |
Operating Profit | 111 | 103 | 67.1 | 75.7 | 76.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 116 | 107 | 79.4 | 67.6 | 77.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 92.7 | 86.6 | 65.8 | 55.6 | 62.1 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 92.7 | 86.6 | 65.8 | 55.6 | 62.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 92.7 | 86.6 | 65.8 | 55.6 | 62.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.8 | 4.47 | 3.39 | 2.88 | 3.23 |
Dividends per Share | |||||
Special Dividends per Share |